AFJOG

VAGINITIS The most common gynaecological problem in primary care. 1 Yet, adequate diagnosis and treatment of vaginitis is often problematic. 2 Discharge Odour Itching Irritation Burning Characterised by: 1 BETADINE® PVP-I has a broad antimicrobial spectrum 3,4 Bacteria Viruses Yeasts Moulds Fungi Protozoa VAGINITIS: THE MOST COMMON GYNAEGOLO PROBLEM IN PRIMARY CARE 15 CHARACTERISED BY 15 : VAGINITIS ACCOUNTS FOR 10% OF ALL DOCTOR VIS WOMEN’S HEALTHCARE 16 AND ARE 6 TIMES MORE C URINARY TRACT INFECTIONS 17 Discharge Odour Itching Irritation IMPACTS QUALITY OF LIFE NEGATIVELY 15 : •Anxiety •Shame •Concerns about hygiene, especially with recurrent symptoms THE THREE MOST COMMON INFECTIONS 19 TRICHOMONIASIS: 5%-20% OF CASES BA VULVOVAGINAL CANDIDIASIS: 20%-35% OF CASES VAGINITIS: THE MOST COMMO GYNAEG PROBLEM IN PRIMARY CARE 15 HA ACTERISED BY 15 : VAGINITIS ACCOUNTS FOR 10% OF ALL DOCT WOM N’S HE LTHCARE 16 AND AR 6 TIMES M URINARY TRACT NFECTIONS 17 Discharge Odour Itching IMPACTS QUALITY OF LIFE NEGATIVELY 15 : •Anxiety •Shame •C ncerns about hygiene, especially wi h recurrent symptoms THE THREE MOST COMMON INFECTIONS 19 TR CHOMONIASIS: 5 -20% OF CASES VULVOVAGINAL CANDIDIASIS: 20 -35% OF CASES VAGINITIS: THE MOST COMMON GYNAEGOLOGI PROBLEM IN PRIMARY CARE 15 CHARACTERISED BY 15 : VAGINITIS ACCOUNTS FOR 10% OF ALL DOCTOR VISITS FO Discharge Odour Itching Irritation IMPACTS QUALITY OF LIFE NEGATIVELY 15 : •Anxiety •Shame •Concerns about hygiene, especially with recurrent symptoms THE THREE MOST COMMON INFECTIONS 19 TRICHOMONIASIS: 5%-20% OF CASES BACTERIAL 40% O VULVOVAGINAL CANDIDIASIS: 20%-35% OF CASES VAGINIT S: THE MOST COMM N GY AEGOLOGICAL PROBLEM IN PRIMARY CARE 15 CHARA TERISED BY 15 : VAGINITIS ACCOUNTS FOR 10% OF ALL DOCTOR VISITS FOR Discharge Odour Itching Irritation Bur IMPACTS QUALITY OF LIFE NEGATIV LY 15 : •Anxiety •Shame •Concerns ab ut hygiene, espec ally with recurrent symptoms THE THREE MOST COMMON INFECTIO S 19 TRICHOMONIASIS: 5%-20 OF CASES BACTERIAL V GINOSI 40%-5 OF CASES VULVOVAGINAL CANDIDIASIS: 20%-35 OF CASES VAGINIT S: THE MOST C M N GY AEGOLOGICAL PROBLEM IN PRIMARY CARE 15 CHARA TERISED BY 15 : VAGINITIS ACCOUNTS FOR 10% OF ALL DOCTOR VISITS FOR Discharge Odour It in Irritation Burning IMPACTS QUALITY OF LIFE NEGATIV LY 15 : •Anxiety •Shame •Concerns about hygiene, esp cially wi h recurr nt ymptoms THE THREE MOST COMMON INFECTI S 19 TRICHOMONIASIS: 5%-20 OF CASES BACTERIAL VAGINOSIS (BV): 40%-5 OF CASES VULVOVAGINA CANDIDIASIS: 20%-35 OF CASES FOR THE TREATMENT OF COMMON VAGINAL INFECTIONS 1 References: 1. PaladineHL, et.al . Vaginitis:DiagnosisandTreatment.AmFamPhysician. 2018.1;97(5):321-329. 2. CarrPL, et.al . EvaluationandmanagementofVaginitis. JGen InternMed.1998;13(5):335-346. 3. Lachapelle J-P, et.al . Antiseptics in theeraofbacterial resistance:A focusonpovidone iodine.ClinPract.2013.10.579-592. 4. ColeGT.BasicBiologyofFungi. In:BaronS,editor.MedicalMicrobiology.4thedition.Galveston (TX):UniversityofTexasMedicalBranchatGalveston;1996.Chapter73 Scheduling status: S2 Proprietaryname (anddosage form):Betadine® VaginalGel. Composition: Each1g containspovidone-iodine100mg,equivalent to10mgavailable iodine. Reg.No.: 51/18.6/0531.For fullprescribing information, refer to the Professional Information as approved by SAHPRA available at: www.inovapharma.co.za. Further information is available on request from iNova Pharmaceuticals. Name and business address of applicant: iNova Pharmaceuticals (Pty) Limited. Co.Reg.No.: 1952/001640/07,15ERileyRoad,Bedfordview. Tel.No. 0110870000.www.inovapharma.co.za. IN5154/25 PHA-108